Clinical Trials Directory

Trials / Terminated

TerminatedNCT05020691

NIV in Covid-19 Respiratory Failure

Non-invasive Ventilation in Covid-19 Respiratory Failure - Predicting Success: A Retrospective Observational Study to Determine Predictive Factors in the Success or Failure of Non-invasive Ventilation.

Status
Terminated
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
National Heatlh Service Ayrshire and Arran · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

A retrospective, single centre observational study to validate use of the HACOR score (Duan et al, 2017) in determining efficacy of non-invasive ventilation in Covid-19 respiratory failure.

Detailed description

The investigators will retrospectively analyse medical records of patients with confirmed Covid-19 respiratory failure who received continuous positive airway pressure (CPAP) via facemask, as per clinician decision, in the High Dependency Unit (HDU) or Intensive Care Unit (ICU) of University Hospital Crosshouse between 1st March 2020 and 30th April 2021. By collecting baseline demographics and physiological data (including APACHE II and clinical frailty score) and calculating the HACOR score at initiation of CPAP, then at 1hr, 6hrs, 12hrs, 24hrs and 48hrs after initiating CPAP the investigators aim to validate use of the HACOR score in determining efficacy of NIV in Covid-19 respiratory failure. The investigators will also collect other variables (CRP and lymphocytes, lactate, mean arterial pressure, temperature) to determine if these factors have utility in predicting efficacy of NIV in Covid-19 respiratory failure.

Conditions

Timeline

Start date
2021-08-18
Primary completion
2021-11-03
Completion
2021-11-03
First posted
2021-08-25
Last updated
2023-11-08

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT05020691. Inclusion in this directory is not an endorsement.

NIV in Covid-19 Respiratory Failure (NCT05020691) · Clinical Trials Directory